Somatic mutations in the Nrf2 gene, KEAP1, and the E3 ubiquitin-ligase complex CUL3 have been recognized in many types of cancer, and these mutations are responsible for Nrf2 activation. This evidence concerns the gene KEAP1 and cancer.